I don’t think Faron has a COO right now. Juho was in that role to grow into the CEO position. Operational management is likely currently handled by the VP, Operations. It’s not C-level; it reports to the CEO and would also report to a COO if one existed.
That fancy-sounding Vice President role, which is mainly a director-level title, is held at Faron by Briton Joab Williamson. His duties include, among others, trial, clinical, and budget management. So, for example, the operational management of research projects and their budget management.
Joab announced a few days ago that he has written a book chapter with Alex Spencer:
Translated like this:
"I’m happy to share that a book chapter I co-authored with my friend and co-writer, Alexander Spicer, has just been published: ‘The Ethics of Optimism: Managing Investor Expectations in Biotech and Pharma.’
It’s part of the Business Ethics in the Healthcare Industry (Springer) course, and it addresses a question most people in the biotech/pharma industry have encountered at some point:
How do you maintain momentum and optimism in external communication without drifting into hype, oversimplifying, or setting expectations that you cannot reasonably meet?
We examine how announcements, headlines, and governance choices shape investor perceptions, why the dynamics between institutional and retail investors are significant, and what ‘constructive transparency’ can look like in practice. Our goal was to promote transparency in drug development beyond just the legal minimum."
Juho and Bono also liked Joab’s post. You can bet that following the Faron thread has provided some juicy bits or at least inspiration for that book. There’s no information on how the institutional investors give feedback. Perhaps via the shareholder list after expert consultations. On the other hand, there is no shortage of feedback from retail investors. How, for example, all communication can be twisted to the extreme—either negative (or positive). If the aforementioned post is seen as a positive, then points for daring to reflect on those questions semi-publicly.